Viewing Study NCT00231556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-02-17 @ 7:41 PM
Study NCT ID: NCT00231556
Status: COMPLETED
Last Update Posted: 2011-06-08
First Post: 2005-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epilepsy View
None Seizures View
None Epilepsies, Partial View
None Epilepsy, Generalized View
None Epilepsy, Tonic-Clonic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epilepsy View
None Seizures View
None Parital Epilepsies View
None Generalized Epilepsy View
None Tonic-Clonic Epilepsy View
None Topiramate View